In recent years, GLP-1 injections have gained traction as a formidable ally in the fight against obesity and type 2 diabetes. These injectable medications, such as semaglutide and liraglutide, mimic the effects of the glucagon-like peptide-1 hormone,

The landscape of weight management and chronic disease treatment is evolving, and one drug that has gained significant attention is semaglutide. Initially approved for type 2 diabetes, this GLP-1 receptor agonist is increasingly being used off-label for

Introduction As the prevalence of diabetes and obesity continues to rise, GLP-1 (glucagon-like peptide-1) medications have emerged as a crucial part of treatment plans. These drugs are designed to help manage blood sugar levels and promote weight